WCG has appointed Sam Srivastava as Chief Executive Officer; Robert VanHees as Chief Financial and Administrative Officer; and Paul Mancinelli, PhD, as Chief Technology Officer.
mdgroup has charged its new VP, Product Delivery, Mohamad (Mo) Merhi with doubling the development team, and appointed LaQuinta Jernigan to Chief Operating Officer.
Dotmatics announced the additions of Larry Samuelson as Chief Legal Officer and Neil Frye as Chief People Officer.
AeroSafe Global announced Jessica Cao joined the company as Senior Vice President of Marketing.
Allucent, announced the appointment of Katy Moore as President of Clinical Pharmacology, Modeling and Simulation.
Walgreens announced several new hires including Kendal Whitlock as Head of Digital Optimization, RWE Clinical Trials; John Campbell as Head of Decentralized Clinical Trials; Liam Wood as Head of Product, RWE Clinical Trials, and Adam Samson as Head of Clinical Delivery Operations, RWE Clinical Trials.
Vitalograph is celebrating 21 years as a clinical trials service provider.
mdgroup has been shortlisted as one of the UK's fastest-growing private companies in the inaugural Sunday Times 100 ranking.
For the seventh consecutive year, Celerion has been named recipient of the Life Science Leader and Clinical Leader’s CRO Leadership Awards in all five award categories.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.